NasdaqGS - Delayed Quote USD
OptiNose, Inc. (OPTN)
At close: October 21 at 4:00 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| CLAVELLI VICTOR M. Officer | Sale | Dec 16, 2022 | 199,955 |
| JANIS MICHELE Chief Financial Officer | Sale | Dec 16, 2022 | 48,927 |
| KOHLER TERRY Chief Financial Officer | Stock Award(Grant) | Oct 7, 2024 | 150,000 |
| KRICK ANTHONY J Officer | Sale | Jul 17, 2024 | 140,758 |
| MAHMOUD RAMY A Chief Executive Officer | Sale | Sep 17, 2024 | 1,374,520 |
| MARINO MICHAEL F III Officer | Sale | Sep 17, 2024 | 547,238 |
| MILLER PETER K Chief Executive Officer | Sale | Jan 13, 2023 | 957,797 |
| MVM PARTNERS, LLC Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Nov 23, 2022 | -- |
| SPENCE PAUL JR. Officer | Stock Award(Grant) | Feb 28, 2024 | 252,675 |
Related Tickers
IRWD Ironwood Pharmaceuticals, Inc.
4.1900
-4.77%
DERM Journey Medical Corporation
6.32
+3.27%
BFRI Biofrontera Inc.
0.9427
+12.23%
ORGO Organogenesis Holdings Inc.
3.1100
-1.58%
AVDL Avadel Pharmaceuticals plc
13.42
-1.07%
SUPN Supernus Pharmaceuticals, Inc.
33.67
-2.52%
PCRX Pacira BioSciences, Inc.
17.33
-0.91%
AKBA Akebia Therapeutics, Inc.
1.3700
+2.24%
ITCI Intra-Cellular Therapies, Inc.
76.91
-1.83%
DRRX DURECT Corporation
1.4300
+8.33%